Physician profile
Mark Daniel Angeloni
NPI 1881047843
$6,998.16
in general payments reported to CMS, 2019-2025
9 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $84.76 · 2021: $520 · 2022: $5,684 · 2023: $396 · 2024: $210 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $709.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $6,400.80 | 2020-2025 | Invisalign |
| American Orthodontics Corporation | $289.20 | 2023-2024 | Master Series, Empower-Metal, Radiance |
| Gc America INC. | $88.93 | 2020-2022 | |
| Envista Holdings Corporation | $79.69 | 2024-2025 | Spark |
| Solventum Corporation | $44.51 | 2025 | Apc Flash-Free Clarity Advanced, 3m |
| Ormco Corporation | $28.36 | 2023 | Spark |
| Nobel Biocare USA | $28.35 | 2023 | Nobelactive |
| Ortho Organizers, INC. | $19.51 | 2021 | |
| Lightforce Orthodontics, INC. | $18.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Angeloni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.